Yiyi Yu

4PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Jun 10, 2026
Targeting ATF3-mediated asparagine biosynthesis reverses acquired resistance to KRAS<sup>G12C</sup> inhibitors.

|Sep 21, 2022
Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway.

Mengling Liu, Xiaojing Xu, Ke Peng

|Nov 11, 2020
Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma.

Wei Li, Qian Li, Yiyi Yu

|Oct 29, 2020
Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients.

Shan Yu, Yan Wang, Xi Cheng

Pageof 1

Frequent Collaborators

3 joint publications

Tianshu Liu

1 joint publications

Xi Cheng

1 joint publications

Li Liang

1 joint publications

Tianshu Liu

1 joint publications

Min Li

1 joint publications

Fan Xu

1 joint publications

Jingyuan Wang

1 joint publications

Rui Wu

Frequent Collaborators

3 joint publications

Tianshu Liu

1 joint publications

Xi Cheng

1 joint publications

Li Liang

1 joint publications

Tianshu Liu

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us